Company intelligence / Profile preview

NewCo Pharma

Mannheim, Germany

Ownership: Private
Employees: ~80
Development stage: Other

Overview

NewCo Pharma specialized in manufacturing patient-specific infusion solutions and sterile drug preparations for specialized pharmacies. The company achieved revenue of €153 million in 2020 with an EBITDA margin of 8.6%, with over 75% of revenue from patient-specific therapies.

Therapeutic areas: OncologyOtherInfectious DiseasesMetabolic Disorders
Modalities: Small molecule
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on NewCo Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NewCo Pharma.

Explore the full profile